Franklin Resources Inc Codiak Bio Sciences, Inc. Transaction History

Franklin Resources Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$10.0 - $16.78 $30,000 - $50,340	-3,000 Reduced 0.9%	330,000 $3.68 Million
Q3 2021 Nov 12, 2021	SELL	$15.58 - $22.88 $5.35 Million - $7.86 Million	-343,513 Reduced 50.78%	333,000 $5.44 Million
Q2 2021 Aug 13, 2021	BUY	$11.72 - $26.81 $796,960 - $1.82 Million	68,000 Added 11.17%	676,513 $12.5 Million
Q1 2021 May 13, 2021	BUY	$13.49 - $31.53 $3.21 Million - $7.51 Million	238,095 Added 64.28%	608,513 $9.18 Million
Q4 2020 Feb 10, 2021	BUY	$7.9 - $32.3 $2.93 Million - $12 Million	370,418 New	370,418 $12 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.